21/06/2024 Healthcare
Piperacillin Tazobactam Injection I.P., marketed as Tamslar 4.5, combines piperacillin, an extended-spectrum penicillin antibiotic, with tazobactam, a β-lactamase inhibitor. Together, they effectively treat moderate to severe bacterial infections by inhibiting bacterial cell wall synthesis and countering β-lactamase enzymes that degrade antibiotics. Administered intravenously, Tamslar 4.5 is crucial for treating infections like intra-abdominal infections and pneumonia caused by resistant organisms. Close medical supervision ensures appropriate dosing and monitoring to optimize therapeutic outcomes while managing potential side effects.Available in PCD Franchise for injectable range and third party manufacturing.
Piperacillin Tazobactam Injection I.P., marketed as Tamslar 4.5, combines piperacillin, an extended-spectrum penicillin antibiotic, with tazobactam, a...
Tranexamic Acid injection IP, branded as Tamslar Injection, is a hemostatic agent used to control excessive bleeding in various medical conditions. Ad...
Triamcinolone Acetonide Injection IP, known as Tioxlin-40 Injection, is a corticosteroid used for its anti-inflammatory and immunosuppressive properti...
Vancomycin for Injection IP, marketed as Satdox Injection, is a potent antibiotic effective against Gram-positive bacteria, including methicillin-resi...
More Details